Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Melanoma Management|January 27, 2025
Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-upDavid J Savage, Benjamin Switzer, Rujul Parikh, et al.
European Journal of Neurology|June 23, 2023
Predictors for the development of neurological immune-related adverse events of immune checkpoint inhibitors and impact on mortalityChen Yan, Merry Huang, Carol Swetlik, et al.
Frontiers in Cardiovascular Medicine|August 26, 2021
Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological MechanismsRishi Rikhi, Jaret Karnuta, Muzna Hussain, et al.
Frontiers in Oncology|June 27, 2022
Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case ReportTapas Ranjan Behera, Jung Min Song, Jennifer Ko, et al.
Journal of the American Academy of Dermatology|September 22, 2018
Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer DatabaseRosalynn R Z Conic, Jennifer Ko, Giovanni Damiani, et al.
BBA Clinical|January 6, 2017
Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinomaPranab K Mukherjee, Pauline Funchain, Mauricio Retuerto, et al.
The Oncologist|October 26, 2018
Cases from the irAE Tumor Board: A Multidisciplinary Approach to a Patient Treated with Immune Checkpoint Blockade Who Presented with a New RashPradnya D Patil, Anthony P Fernandez, Vamsidhar Velcheti, et al.
The Oncologist|March 11, 2023
Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care CenterNatalie Farha, Muhammad Salman Faisal, Daniela S Allende, et al.
Pigment Cell & Melanoma Research|March 5, 2025
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline VariantsIsabella Ribaudo, Michelle Arbesman, Ying Ni, et al.
Melanoma Research|May 15, 2020
Utilization and impact of immunotherapy in stage IV melanoma using the National Cancer DatabaseRosalynn R Z Conic, Rebecca Knackstedt, Tamara A Sussman, et al.
Pageof 9